Azerbaijan vs Bosnia and Herzegovina: Hepatitis B surface antigen (HBsAg) prevalence
Azerbaijan
0.3%
in 2024
Bosnia and Herzegovina
0.3%
in 2024
Azerbaijan rank
71st
Bosnia and Herzegovina rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Azerbaijan
- Bosnia and Herzegovina
How they compare
Azerbaijan currently reports 0.3% against 0.3% in Bosnia and Herzegovina, a difference of 0.0%.
Across all 10 years both countries report, Bosnia and Herzegovina has been ahead every year.
Azerbaijan ranks 71st and Bosnia and Herzegovina ranks 71st of 194 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Bosnia and Herzegovina | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Bosnia and Herzegovina |
| 2020s | 0.3% | 0.3% | 0.1% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Azerbaijan or Bosnia and Herzegovina?
- Azerbaijan, at 0.3% against 0.3% in Bosnia and Herzegovina as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Azerbaijan and Bosnia and Herzegovina?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Bosnia and Herzegovina?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Bosnia and Herzegovina rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Azerbaijan ranks 71st and Bosnia and Herzegovina ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.